HomeNDC LookupIngredients › Pembrolizumab And Berahyaluronidase Alfa
📦 NDC / package directory — not a drug information page

Pembrolizumab And Berahyaluronidase Alfa NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Pembrolizumab And Berahyaluronidase Alfa products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

2
Package NDCs
2
Products
2
Active listings
0
Discontinued
1
Labelers
1
Strengths
1
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
BERAHYALURONIDASE ALFA 2000 U/mL;... 2
By dosage form
INJECTION, SOLUTION 2
Top labelers
BSP Pharmaceuticals S.p.A. 2

Browse records — 2 products

Drug / product Billing NDC NADAC / unit Status
pembrolizumab and berahyaluronidase alfa 2000 U/mL; 165 mg/mL INJECTION, SOLUTION BSP · NDC 43624-0030-01 · 221 VIAL in 1 TRAY (43624-030-01) / 2.4 mL in 1 VIAL 43624-0030-01 On market View →
pembrolizumab and berahyaluronidase alfa 2000 U/mL; 165 mg/mL INJECTION, SOLUTION BSP · NDC 43624-0031-01 · 130 VIAL in 1 TRAY (43624-031-01) / 4.8 mL in 1 VIAL 43624-0031-01 On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.